Patrick Neven

No ORCID on file · 13 papers in corpus · active 1989-2020

Study types

  • article 7
  • letter 4
  • review 2

Condition tags

  • endometriosis 2
letter 2020
Uterine ultrasound and endometrial biopsy in tamoxifen users
·doi:10.1007/s10549-020-05595-5
article 2011
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass
·doi:10.1097/gme.0b013e318223bbf4

OBJECTIVE: The aim of this study was to report the gynecologic safety findings from the Generations trial, a phase 3 study of the selective estrogen receptor modulator (SERM), arzoxifene. METHODS: A predefined objective of the trial was to …

letter 2006
Aromatase Inhibitors in Premenopausal Women: The Need for Proper Contraceptive Counseling
·doi:10.1111/j.1075-122x.2006.00318.x
review 2004
Endometriosis and the development of malignant tumours of the pelvis. A review of literature
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2003.03.001

For several decades, endometriosis has been suspected of playing a role in the aetiology of ovarian cancer. The literature concerning a possible histogenesis of ovarian cancer from benign endometriosis is reviewed in this chapter. Epidemiol…

review 2002
Endometrial safety of hormone replacement therapy: review of literature
Maturitas ·doi:10.1016/s0378-5122(02)00031-2

Unopposed estrogens for treating menopausal symptoms were extensively used when epidemiological findings associated them with an increased endometrial cancer risk. Adding progestogens reverse this side effect efficiently but patient, dose, …

article 2000
Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium
·doi:10.1016/s0959-8049(00)00263-x
article 1998
II.2 Tamoxifen and benign endometrial lesions
·doi:10.1016/s0959-8049(98)00091-4
article 1998
III.1 Tamoxifen and the uterus—the hysteroscopic approach
·doi:10.1016/s0959-8049(98)00098-7
letter 1994
Effects of tamoxifen on uterus
·doi:10.1016/s0140-6736(94)92013-3
article 1991
Endometrial lesions in patients undergoing tamoxifen therapy
·doi:10.1016/0020-7292(91)90767-y

Forty-six nonhysterectomized women treated with tamoxifen during 6-36 months as adjuvant therapy for breast cancer underwent a hysteroscopy to assess the endometrial effects of this drug. Whereas the endometrium was normal among 23 patients…

letter 1990
Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy
·doi:10.1111/j.1471-0528.1990.tb02536.x
article 1990
Hysteroscopic follow-up during Tamoxifen treatment
·doi:10.1016/0028-2243(90)90167-y
article 1989
TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM
·doi:10.1016/s0140-6736(89)91741-8